PMID: 28356591DOI: 10.1038/nrd.2017.57Mar 31, 2017Paper

PRIME time at the EMA

Nature Reviews. Drug Discovery
Asher Mullard

Abstract

No abstract listed.

Citations

Clinical Development and Initial Approval of Novel Immune Checkpoint Inhibitors in Oncology: Insights From a Global Regulatory Perspective

Jun 21, 2018·Clinical Pharmacology and Therapeutics·Philippe SerranoChristine Mayer-Nicolai

Clinical development of CAR T cells-challenges and opportunities in translating innovative treatment concepts

Aug 3, 2017·EMBO Molecular Medicine·Jessica HartmannChristian J Buchholz

European Medicines Agency's Priority Medicines Scheme at 2 Years: An Evaluation of Clinical Studies Supporting Eligible Drugs

Oct 9, 2019·Clinical Pharmacology and Therapeutics·Emilie NeezHuseyin Naci

Global Regulatory Differences for Gene- and Cell-Based Therapies: Consequences and Implications for Patient Access and Therapeutic Innovation

Oct 7, 2017·Clinical Pharmacology and Therapeutics·Delphi G M CoppensJarno Hoekman

Expanded access to investigational drugs: balancing patient safety with potential therapeutic benefits

Jan 23, 2018·Expert Opinion on Investigational Drugs·Elena FountzilasApostolia M Tsimberidou

Biased by design? Clinical trials and patient benefit in oncology

Dec 12, 2019·Future Oncology·Pan PantziarkaLydie Meheus

Strengthening regulatory science in academia: STARS, an EU initiative to bridge the translational gap.

Nov 1, 2020·Drug Discovery Today·Viktoriia StarokozhkoUNKNOWN STARS consortium

First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G.

Mar 20, 2021·Journal for Immunotherapy of Cancer·François AnnaJulien Caumartin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Related Papers

EMA provides first glimpse of PRIME candidates

(opens in new tab)
Nature Reviews. Drug Discovery
Asher Mullard

E.M.--a compelling new specialty

(opens in new tab)
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
C Bateman

New EMA guideline for antimicrobial development

(opens in new tab)
The Lancet Infectious Diseases
Paul G AmbroseGeorge L Drusano

EMA urgently needs a cure

(opens in new tab)
BMJ : British Medical Journal
Alain Braillon
ContactHelpTerms Privacy Cookies
© 2022 Meta ULC. All rights reserved